help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2008-2327
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishikawa, H.
Right arrow Articles by Bulun, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishikawa, H.
Right arrow Articles by Bulun, S. E.
Related Collections
Right arrow Endocrine Oncology
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 94, No. 5 1752-1756
Copyright © 2009 by The Endocrine Society


BRIEF REPORT

High Aromatase Expression in Uterine Leiomyoma Tissues of African-American Women

Hiroshi Ishikawa, Scott Reierstad, Masashi Demura, Alfred W. Rademaker, Tadayuki Kasai, Masaki Inoue, Hirokazu Usui, Makio Shozu and Serdar E. Bulun

Division of Reproductive Biology Research (H.I., S.R., M.D., S.E.B.), Department of Obstetrics and Gynecology, Feinberg School of Medicine at Northwestern University, and Biostatistics Core Facility (A.W.R.), Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611; Department of Obstetrics and Gynecology (T.K., M.I.), Kanazawa University Graduate School of Medicine, Takaramachi, Kanazawa-shi, Ishikawa-ken 920-8641, Japan; and Department of Reproductive Medicine (H.U., M.S.), Graduate School of Medicine, Chiba University, Chuo-ku, Chiba-shi 260-8670, Japan

Address all correspondence and requests for reprints to: Serdar E. Bulun, M.D., Professor and Chief, Division of Reproductive Biology Research, Department of Obstetrics and Gynecology, Feinberg School of Medicine at Northwestern University, 303 E. Superior Street, Suite 4-123, Chicago, Illinois 60611. E-mail: s-bulun{at}northwestern.edu.

Context: Symptomatic uterine leiomyoma is associated with irregular uterine bleeding, anemia, and recurrent pregnancy loss. African-American women develop uterine leiomyomas at an earlier age and with higher frequency compared with Caucasian-American women or other races; however, the underlying mechanism for this discrepancy is unknown.

Objective: Our objective was to determine whether gene targets of emerging leiomyoma therapeutics such as aromatase inhibitors and antiprogestins, which reduce tumor size and symptoms, are differentially expressed in tissues of African-American (n = 31), Caucasian-American (n = 34), and Japanese women (n = 36).

Results: We found strikingly higher aromatase mRNA levels in leiomyoma compared with adjacent myometrium in African-American (83 fold), Caucasian-American (38 fold), and Japanese women (33 fold). Among the four major promoters that regulate aromatase expression in leiomyoma, the proximal promoter II accounted for higher aromatase mRNA levels in tissues from African-American women. Estrogen receptor subtype {alpha} mRNA levels were significantly, and 1.8- to 2.6-fold, higher in leiomyoma compared with adjacent myometrium in all groups, whereas leiomyoma estrogen receptor subtype β mRNA levels were significantly elevated only in Japanese women. Leiomyoma progesterone receptor mRNA levels were significantly higher in Japanese women compared with African-American or Caucasian-American women.

Conclusions: Leiomyoma tissues from African-American women contained the highest level of aromatase expression, which may result in elevated tissue concentrations of estrogen, and account for the higher prevalence and earlier incidence. Analysis of leiomyoma tissue for biomarkers may predict the response to hormonal treatments such as aromatase inhibitors.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
X. Luo, P. Yin, S. Reierstad, H. Ishikawa, Z. Lin, M. E. Pavone, H. Zhao, E. E. Marsh, and S. E. Bulun
Progesterone and Mifepristone Regulate L-Type Amino Acid Transporter 2 and 4F2 Heavy Chain Expression in Uterine Leiomyoma Cells
J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4533 - 4539.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
W. Bowden, J. Skorupski, E. Kovanci, and A. Rajkovic
Detection of novel copy number variants in uterine leiomyomas using high-resolution SNP arrays
Mol. Hum. Reprod., September 1, 2009; 15(9): 563 - 568.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society